While CT scans have been postponed for weeks or months after a COVID-19-related shutdown interrupted one plant's contrast dye production, hospitals could decrease their use up to 83 percent, according to research published June 9 in JAMA. 

Tampon manufacturers and suppliers are running to meet a higher demand, which could be the next supply shortage the healthcare industry faces, according to Time. 

A former Abbott employee submitted an Occupational Safety and Health Administration complaint in February 2021, months before the baby formula-producing plant in Sturgis, Mich., stopped operations, The Wall Street Journal reported June 8.

The contrast dye shortage, caused by COVID-19 lockdowns in China, has spurred leaders at healthcare systems across the nation to come up with innovative solutions to continue services with rationed supplies.

Minneapolis-based Medtronic recalled 1,614 pump implants developed for the company's HeartWare ventricular assist device, which the FDA deemed a class 1 recall, the highest level, June 8. 

After failing to pass another COVID-19 relief package, the federal government is veering off course and investing $10 billion for vaccines and the antiviral treatment Paxlovid originally marked for tests and personal protective equipment, The New York Times reported.

Technology research firm Gartner ranked 55 supply chain undergraduate programs and graded the top 25 in North America. 

With a $150 million check, medical supply company Health Supply US will break ground in Greenville, S.C., with a new Glove One factory. 

President Joe Biden's Operation Fly Formula tacked on a fifth flight to import baby formula amid the national shortage. The plane from Cologne, Germany, will land on a runway in Fort Worth, Texas, on June 9. 

Philips Respironics recalled all V60 and V60 Plus Ventilators on June 3 over a power issue that may cause the devices to shut down without an alarm.

As the number of confirmed monkeypox national cases creeps up to 25 across 12 states as of June 5, the HHS has a stockpile of about 36,000 monkeypox vaccine doses, according to CNBC. 

Biopharmaceutical company Pfizer will manufacture materials for the antiviral drug Paxlovid in Kalamazoo, Mich., after a $120 million investment for the treatment's first stateside factory.

The catalyst for the national baby formula shortage, Abbott's plant in Sturgis, Mich., restarted production June 4 after a monthslong closure due to contamination. 

Production of an X-ray imaging dye at a Shanghai plant will resume at normal speed this week after COVID-19-related shutdowns halted supply in May.

Coverage on global contrast dye shortages affecting patient care was the most-read supply chain story Becker's reported last month. 

The national baby formula shortage is worsening, despite federal efforts to increase manufacturing and accelerate imports from other countries, The New York Times reported June 1.

Here are 10 health systems that have posted job listings for supply chain expertise in the last week: 

The infant formula shortage will likely last until late July, FDA Commissioner Robert Califf, MD, said during a Senate Health Committee meeting, The Hill reported May 26.

Abott recalled 4,800 Dragonfly OpStar imaging catheters May 26 due to the marker band becoming loose and, in two instances, separating from the device. 

Coral Gables, Fla.-based Baptist Health South Florida and Medline entered a partnership May 24 to "identify new strategies for enhancing data-driven operational and clinical efficiencies."